Business
Result of general meeting
Result of general meeting.
About this update from Hvivo Plc
[{"type":"text","content":"\n \nRNS Number : 5839D Venn Life Sciences Holdings PLC 31 March 2014 \n \n\n\nVenn Life Sciences Holdings Plc \n(\"Venn\" or the \"Company\")\n \nResult of general meeting\n \nVenn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that at the General Meeting held earlier today, all the resolutions put to shareholders were duly passed. \n \nAs a result, the Placing announced on 14 March 2014 of 5,263,158 new ordinary shares at 19p per ordinary share, is conditional only on Admission which is expected to take place on 2 April 2014. \n \nThe Directors intend to use the net proceeds of the Placing to develop the opportunities provided by the recent acquisition of Labskin™ and the SYN1113 intellectual property rights.\n \nFollowing Admission, the Company's issued share capital will consist of 28,190,441 ordinary shares. There are no ordinary shares held in treasury. Therefore, in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that following Admission, the total number of voting rights in the Company will be 28,190,441.\n \n \nEnquiries:\n \nVenn Life Sciences Holdings Plc \nTony Richardson, Chief Executive Officer Tel: +353 154 99 341\nPaul Foulger, Finance Director Tel: 020 7933 8797\nOrla McGuinness, Marketing Manager &...